These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 2226217)

  • 1. Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential.
    Langtry HD; Benfield P
    Drugs; 1990 Aug; 40(2):291-313. PubMed ID: 2226217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zolpidem for insomnia.
    Greenblatt DJ; Roth T
    Expert Opin Pharmacother; 2012 Apr; 13(6):879-93. PubMed ID: 22424586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia.
    Hoehns JD; Perry PJ
    Clin Pharm; 1993 Nov; 12(11):814-28. PubMed ID: 8275648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.
    Holm KJ; Goa KL
    Drugs; 2000 Apr; 59(4):865-89. PubMed ID: 10804040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contribution of zolpidem in the management of sleep disorders].
    Lavoisy J; Zivkovic B; Benavides J; Perrault GH; Robert P
    Encephale; 1992; 18(4):379-92. PubMed ID: 1363657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological profile and clinical effect of zolpidem (Myslee tablets), a hypnotic agent].
    Shirakawa K
    Nihon Yakurigaku Zasshi; 2002 Feb; 119(2):111-8. PubMed ID: 11862759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications.
    Salvà P; Costa J
    Clin Pharmacokinet; 1995 Sep; 29(3):142-53. PubMed ID: 8521677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zolpidem: a review of its use in the management of insomnia.
    Swainston Harrison T; Keating GM
    CNS Drugs; 2005; 19(1):65-89. PubMed ID: 15651908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
    J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zolpidem's use for insomnia.
    Monti JM; Spence DW; Buttoo K; Pandi-Perumal SR
    Asian J Psychiatr; 2017 Feb; 25():79-90. PubMed ID: 28262178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
    Barkin RL
    Am J Ther; 2007; 14(3):299-305. PubMed ID: 17515707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and tolerability of zolpidem--an update.
    Darcourt G; Pringuey D; Sallière D; Lavoisy J
    J Psychopharmacol; 1999; 13(1):81-93. PubMed ID: 10221362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zolpidem: distinct from triazolam?
    Lobo BL; Greene WL
    Ann Pharmacother; 1997 May; 31(5):625-32. PubMed ID: 9161660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of zolpidem in the management of insomnia.
    Dang A; Garg A; Rataboli PV
    CNS Neurosci Ther; 2011 Oct; 17(5):387-97. PubMed ID: 20553305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zolpidem, a valuable alternative to benzodiazepine hypnotics for chronic insomnia?
    Declerck A; Smits M
    J Int Med Res; 1999; 27(6):253-63. PubMed ID: 10726234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual zolpidem (Edluar™; Sublinox™).
    Yang LP; Deeks ED
    CNS Drugs; 2012 Nov; 26(11):1003-10. PubMed ID: 23034583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically important drug interactions with zopiclone, zolpidem and zaleplon.
    Hesse LM; von Moltke LL; Greenblatt DJ
    CNS Drugs; 2003; 17(7):513-32. PubMed ID: 12751920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia.
    Staner L; Danjou P; Luthringer R
    Expert Rev Neurother; 2012 Feb; 12(2):141-53. PubMed ID: 22288669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study.
    Roehrs TA; Randall S; Harris E; Maan R; Roth T
    J Psychopharmacol; 2012 Aug; 26(8):1088-95. PubMed ID: 22004689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.